摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid tris(hydroxymethyl)methylamine

中文名称
——
中文别名
——
英文名称
(-)-2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid tris(hydroxymethyl)methylamine
英文别名
2-Amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-(4-hydroxyphenyl)ethylsulfanyl]-3-[4-[2-(4-methylsulfonyloxyphenoxy)ethyl]phenyl]propanoic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-(4-hydroxyphenyl)ethylsulfanyl]-3-[4-[2-(4-methylsulfonyloxyphenoxy)ethyl]phenyl]propanoic acid
(-)-2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid tris(hydroxymethyl)methylamine化学式
CAS
——
化学式
C4H11NO3*C26H28O7S2
mdl
——
分子量
637.772
InChiKey
XRKFHPWQROUMGX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.98
  • 重原子数:
    43
  • 可旋转键数:
    16
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    231
  • 氢给体数:
    6
  • 氢受体数:
    12

反应信息

点击查看最新优质反应信息

文献信息

  • Amine salts of (-)-2-{2-(4-hydroxyphenyl) ethyl]thio} -3-4-(2-{4-(methylsulfonyl) oxy phenyl propanoic acid and their use in medicine
    申请人:Ahlqvist Matti
    公开号:US20070099928A1
    公开(公告)日:2007-05-03
    A tert-butylamine salt, a piperazine salt, a choline salt, a tris(hydroxymethyl)methylamine salt, a lysine salt or an adamantylamine salt of (−)-2-[2-(4-hydroxyphenyl)ethyl]thio}-3-[4(2-4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid processes for their preparation, their use in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance and other manifestations of the metabolic syndrome, and pharmaceutical compositions containing them.
    (−)-2-[2-(4-羟基苯基)乙基]硫代}-3-[4(2-4-[(甲基磺酰氧)苯氧基]乙基}苯基)丙酸的叔丁基胺盐、哌嗪盐、胆碱盐、三(羟甲基)甲基胺盐、赖氨酸盐或金刚烷胺盐的制备方法,它们在治疗临床病症,包括与胰岛素抵抗和其他代谢综合征表现有无关的脂质紊乱(失调)方面的应用,以及含有它们的制药组合物。
  • AMINE SALTS OF (-)-2- ¬2-(4-HYDROXYPHENYL)ETHYL|-THIO -3-¬4-(2- 4-¬(METHYLSULFONYL)OXY|PHENOXY ETHYL)PHENYL|PROPANOIC ACID AND THEIR USE IN MEDICINE.
    申请人:AstraZeneca AB
    公开号:EP1638930A1
    公开(公告)日:2006-03-29
  • [EN] AMINE SALTS OF (-)-2-{`2-(4-HYDROXYPHENYL) ETHYL!-THIO}-3-`4-(2-{4-`(METHYLSULFONYL)OXY! PHENOXY}ETHYL)PHENYL! PROPANOIC ACID AND THERE USE IN MEDICINE<br/>[FR] SELS AMINE D'ACIDE (-)-2-{`2-(4-HYDROXYPHENYL)ETHYL!-THIO}-3-`4-(2-{4-`(METHYLSULFONYL)OXY!PHENOXY}ETHYL)PHENYL!PROPANOIQUE ET LEUR UTILISATION EN MEDECINE
    申请人:ASTRAZENECA AB
    公开号:WO2004113283A1
    公开(公告)日:2004-12-29
    A tert-butylamine salt, a piperazine salt, a choline salt, a tris(hydroxymethyl)methylamine salt, a lysine salt or an adamantylamine salt of (-)-2-[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid processes for their preparation, their use in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance and other manifestations of the metabolic syndrome, and pharmaceutical compositions containing them.
    一种(-)-2-[2-(4-羟基苯基)乙基]硫基}-3-[4-(2-4-[(甲磺氧基)氧基]苯氧基}乙基)苯基]丙酸的叔丁胺盐、哌嗪盐、胆碱盐、三(羟甲基)甲基胺盐、赖氨酸盐或金刚烷胺盐的制备方法,以及它们在治疗临床病症中的应用,包括与胰岛素抵抗和代谢综合征其他表现有关的脂质紊乱(脂质代谢异常),以及含有它们的药物组合物。
查看更多